Olive Tree Capital

Olive Tree Capital is a Boston-based venture capital firm that specializes in early-stage and growth investments, as well as turnaround capitalization and secondary market pre-IPO stock. Established in 2013, the firm seeks diverse global investment opportunities across various sectors, including public markets, film, real estate, hospitality, franchising, licensing, and natural resources. With a focus on identifying discrepancies between market perception and fundamental reality, Olive Tree Capital emphasizes collaboration with entrepreneurs and businesses that contribute positively to society while pursuing profitability. The firm operates under a philosophy that values clarity, dedication, and the Golden Rule, highlighting its commitment to meaningful partnerships and ethical investment practices.

Joseph Lissak

Principal

40 past transactions

Curacel

Seed Round in 2023
Curacel is a leading developer of a healthcare data platform in Africa, focused on transforming operations within the healthcare sector. The company provides productivity tools and IT infrastructure that empower healthcare stakeholders to digitize their business processes, facilitating connections across various entities and enabling data-driven decision-making. Curacel's platform utilizes advanced artificial intelligence to automate claim processing and detect fraud, thereby enhancing operational efficiency for insurance companies. By aiming to create a connected healthcare ecosystem in low-income economies, Curacel seeks to optimize resource allocation, improve patient outcomes, and support research and public health initiatives in Africa through comprehensive data access.

Craniometrix

Seed Round in 2022
Craniometrix is a D2C SaaS solution that screens cognitive impairment in a simple, cost-effective, and accurate manner. they help to detect of Alzheimer's disease, even years before symptoms appear.

YourChoice Therapeutics

Series A in 2022
YourChoice Therapeutics, Inc. is a biotechnology company focused on developing and manufacturing non-hormonal contraceptive products for women. Founded in 2018 and headquartered in Berkeley, California, the company has created a technology that utilizes an active compound to inhibit sperm motility, thereby preventing fertilization. This innovative approach aims to provide safer birth control options that eliminate the risks associated with traditional hormonal methods, offering users a solution with potentially fewer side effects. The company's commitment to advancing reproductive health is reflected in its focus on developing effective and safe contraceptive alternatives.

Kindly

Seed Round in 2022
Kindly Health is a diagnostics platform focused on sexual care and performance health, offering comprehensive solutions for various reproductive health concerns. The company addresses issues such as sperm health and sexual performance in men, as well as low libido, polycystic ovary syndrome (PCOS), irregular periods, and menstrual pain in women. Kindly Health enhances accessibility to its services by providing at-home diagnostic tests, including semen analysis and PCOS assessments, alongside telehealth consultations and nutraceutical supplements. Additionally, the platform employs artificial intelligence and computer vision technology to assist in selecting optimal embryos, thereby improving the success rates of assisted reproductive procedures. Overall, Kindly Health aims to make fertility treatments and sexual health care more affordable and accessible for patients.

10club

Series A in 2022
10club acquires small brands that sell their products on e-commerce platforms and scales those businesses.

LIV

Series A in 2022
LIV Inc, formerly known as LIV Net Inc, is a technology company based in Prague, Czech Republic, specializing in virtual reality software for gaming. Established in 2013, LIV focuses on enabling VR live streamers to engage with their audiences in real-time, transforming viewers from passive spectators into active participants. Since its inception, the company has redefined the landscape of live-streamed gaming content, allowing creators to enhance their interactive experiences. Since launching in 2018, LIV's innovative approach has garnered over 1.5 billion views, showcasing its significant impact on the virtual reality and gaming communities.

Kindly His

Seed Round in 2022
Janani aims to make the process of infertility treatment and assisted fertilization easier and more affordable for the masses.

Finless Foods

Series B in 2022
Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.

Konta

Seed Round in 2022
Konta is an online accounting service based in Monterrey, Mexico, focused on assisting micro and small businesses. Founded in September 2019 by José Menéndez and Pablo Icaza, Konta aims to simplify business operations for freelancers and small entrepreneurs through a cost-effective and automated platform. The service enables users to generate invoices, maintain accounting records, and supports electronic tax filing, facilitating efficient financial management. By providing these tools, Konta helps small businesses navigate their accounting needs more easily.

Axelar

Series B in 2022
Developer of a decentralized interoperability software designed to connect blockchain ecosystems and applications with users. The company's software is powered by byzantine consensus, cryptography, and mechanism design protocols that let applications live on different blockchains to communicate with each other, enabling users to get a distributed network, APIs, and tools to make it easy to build cross-chain decentralized applications.

Gauzy

Series D in 2022
Gauzy is currently a leading provider of turnkey liquid crystal glass projects, installing laminated LC films in different applications such as home appliances, architecture, construction, automotive industry and many other segmented markets. Their patent pending innovative control technologies enable us to handle glass like never before – Dim glass with numerous stages of transparency, create in-glass blinds, insert transparent solar cells into glass windows, and achieve various glass related innovations in the automotive and aviation industries.

Hubpay

Series A in 2022
Hubpay Technologies Ltd. operates Hubpay, a digital wallet designed for facilitating low-cost remittances and international bill payments in the United Arab Emirates. Founded in 2019 and based in Dubai, the platform aims to enhance financial inclusion in emerging markets by supporting both the remittance and mobile money sectors. Hubpay provides a user-friendly solution for individuals sending and receiving money, contributing to easier access to financial services in the region.

Regent

Venture Round in 2022
Regent is a maritime mobility company founded in 2020 and headquartered in Winchester, Massachusetts. The company specializes in developing all-electric sea gliders designed to provide fast, safe, and cost-effective coastal transportation. These innovative machines fly just above the water's surface, serving as a replacement for traditional ferries and short-haul aircraft on coastal routes. By combining the high speed of an airplane with the lower operating costs of a boat, Regent aims to enhance local and regional transportation options between coastal cities, improving accessibility and efficiency for its customers.

DermBiont

Series A in 2021
DermBiont is a biotech company that develops skin microbiome therapeutics to treat and prevent skin diseases. It is at the intersection of two highly active sectors: dermatology and the microbiome. They harness naturally occurring microbes on the human skin that have evolved over hundreds of thousands of years to compete with pathogenic microbes (fungi, bacteria, viruses, etc.). The company was founded in 2017 and is headquartered in Boston, Massachusetts with a satellite office in Emeryville, California.

Stack Finance

Seed Round in 2021
Stack is a smart mobile finance platform for the millennial and gen-z generation, designed to help people lead healthier financial lives and automate their savings, spending and investments along with their friends and family. We’re not a standard start-up, our founding team is comprised of serial entrepreneurs who have done it before and want to do it bigger and better. At the heart of this transformation, our team is building the technology, design, user experience, workflows, and methodologies that will be used to profoundly change the way we all manage our financial lives.

Defy

Seed Round in 2021
Defy is Indian-based cryptocurrency exchange platform.

Cheeze

Seed Round in 2021
Cheeze is a social platform designed for families and close friends to share and capture memories. It enables users to create and manage private communities through chat, available on both iOS and Android. The platform allows users to mint their collections using a minting studio and offers a marketplace for discovering and collecting NFT photography. Cheeze distinguishes itself by providing zero gas fees and utilizing blockchain technology for security, enabling users to track and manage NFT sales effectively. This approach allows for a curated experience while facilitating the sharing and preservation of personal memories in a digital format.

Lark

Series D in 2021
Lark Technologies, Inc. is a developer of a chronic disease prevention and management platform headquartered in Mountain View, California. Founded in 2010, the company provides the Lark application, which utilizes artificial intelligence alongside human coaching to deliver personalized, real-time support for individuals managing chronic conditions such as diabetes, prediabetes, and hypertension. The platform also integrates data on user activity, sleep, and nutrition to enhance health outcomes. Lark's programs, including its CDC-recognized Diabetes Prevention Program and Hypertension Program, have garnered around 1.5 million users and are backed by clinical evidence published in peer-reviewed journals. The company serves employers and health plans, aiming to deliver compassionate care at scale.

Joy

Series A in 2021
Joy Life, Inc. is a San Francisco-based company that offers a comprehensive wedding planning portal and application designed to assist users from engagement through to their honeymoon. Founded in 2014, Joy's platform provides tools for organizing wedding details, including customizable checklists, wedding websites, and mobile applications. Users can manage guest lists, send digital or printed invitations, track RSVPs, and link gift registries. The application also fosters interaction among wedding guests by allowing photo sharing and comments on a private timeline. Additionally, Joy offers features for sending custom notifications and messages, enabling a seamless planning experience for couples and their wedding parties.

Ramp

Series C in 2021
Ramp is a technology company based in New York that specializes in corporate credit cards and spending management solutions for businesses and startups. Founded in 2019, Ramp's corporate card offers tools for tracking expenses and gaining insights, alongside cashback rewards for purchases made at various retailers. The company aims to streamline corporate spending by providing higher card limits, automated expense management, and seamless integration with accounting systems. Ramp was founded by the team behind Paribus, known for facilitating automated savings on online purchases. Additionally, Ramp Holdings, an entity with a longer history, focuses on video management and delivery solutions, enabling organizations to optimize video content through advanced search, delivery, and monetization capabilities. Originally established in 1948 and based in Boston, this subsidiary of Raytheon BBN Technologies utilizes innovative technologies such as speech-to-text and natural language processing to enhance video experiences across numerous industries.

Mendel

Series A in 2021
Mendel.ai develops artificial intelligence-based solutions aimed at enhancing clinical oncology research and improving patient care. Founded in 2005 and headquartered in San Jose, California, the company offers a range of software solutions that address various challenges in the clinical trial process. Its products include Read, which provides instant data abstraction; Retina, designed to minimize data loss during optical character recognition; Redact, which addresses privacy concerns in patient record sharing; Research, a clinical search engine; Recruit, facilitating patient prescreening and enrollment; and Enrich, which offers real-time access to real-world data from leading oncology clinics. By transforming unstructured electronic medical records and clinical literature into analytics-ready data, Mendel.ai aims to streamline global oncology research and automate clinical trials.

Mamo

Series A in 2021
Mamo Pay is a financial technology company that specializes in a peer-to-peer payments application, founded in 2016 and headquartered in Dubai, United Arab Emirates. The application allows users to transfer, receive, track, and split payments with family, friends, and businesses without incurring any fees. Mamo Pay enables users to connect their bank accounts, facilitating quick and secure money transfers. Additionally, the platform supports global payments in multiple currencies, offers virtual card issuance, and integrates with e-commerce platforms. This functionality helps businesses optimize their financial operations and gain insights into spending patterns.

Excision

Venture Round in 2021
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, that specializes in the development of gene editing therapeutics targeting life-threatening diseases caused by neurotropic viruses. Founded in 2015, the company employs CRISPR-based technology to create innovative treatments that aim to eradicate or disrupt viral genes in human patients. Excision is committed to advancing these therapeutics into safe and effective medicines, addressing significant medical needs and improving the quality of life for individuals affected by viral infections.

Excision

Series A in 2021
Excision BioTherapeutics Inc. is a life science company based in Philadelphia, Pennsylvania, that specializes in the development of gene editing therapeutics targeting life-threatening diseases caused by neurotropic viruses. Founded in 2015, the company employs CRISPR-based technology to create innovative treatments that aim to eradicate or disrupt viral genes in human patients. Excision is committed to advancing these therapeutics into safe and effective medicines, addressing significant medical needs and improving the quality of life for individuals affected by viral infections.

Lark

Series C in 2020
Lark Technologies, Inc. is a developer of a chronic disease prevention and management platform headquartered in Mountain View, California. Founded in 2010, the company provides the Lark application, which utilizes artificial intelligence alongside human coaching to deliver personalized, real-time support for individuals managing chronic conditions such as diabetes, prediabetes, and hypertension. The platform also integrates data on user activity, sleep, and nutrition to enhance health outcomes. Lark's programs, including its CDC-recognized Diabetes Prevention Program and Hypertension Program, have garnered around 1.5 million users and are backed by clinical evidence published in peer-reviewed journals. The company serves employers and health plans, aiming to deliver compassionate care at scale.

Mamo

Seed Round in 2020
Mamo Pay is a financial technology company that specializes in a peer-to-peer payments application, founded in 2016 and headquartered in Dubai, United Arab Emirates. The application allows users to transfer, receive, track, and split payments with family, friends, and businesses without incurring any fees. Mamo Pay enables users to connect their bank accounts, facilitating quick and secure money transfers. Additionally, the platform supports global payments in multiple currencies, offers virtual card issuance, and integrates with e-commerce platforms. This functionality helps businesses optimize their financial operations and gain insights into spending patterns.

Alto Pharmacy

Series D in 2020
Alto is a full-service pharmacy powered by a team of experts dedicated to making your doctor's orders their own. From delivering prescriptions to coordinating with insurance, digging for discounts, and answering, Alto works behind-the-scenes to remove any obstacles standing in the way of your care. The company started in 2015 and is headquartered in San Francisco, California.

Alto Pharmacy

Series C in 2019
Alto is a full-service pharmacy powered by a team of experts dedicated to making your doctor's orders their own. From delivering prescriptions to coordinating with insurance, digging for discounts, and answering, Alto works behind-the-scenes to remove any obstacles standing in the way of your care. The company started in 2015 and is headquartered in San Francisco, California.

Boom Supersonic

Series B in 2019
Boom Supersonic is focused on revolutionizing passenger air travel by developing a supersonic airliner called Overture, which is designed to achieve speeds of Mach 2.2. Founded in 2014 and based in Englewood, Colorado, the company aims to make supersonic flights accessible and affordable for business travelers, while also promoting sustainability in aviation. Overture features advanced aerodynamics and engines that support the use of next-generation sustainable alternative fuels, enhancing safety and efficiency. Boom Supersonic is committed to overcoming the challenges associated with supersonic flight, with the ultimate goal of establishing routine supersonic travel for passengers worldwide.

Boom Supersonic

Series B in 2018
Boom Supersonic is focused on revolutionizing passenger air travel by developing a supersonic airliner called Overture, which is designed to achieve speeds of Mach 2.2. Founded in 2014 and based in Englewood, Colorado, the company aims to make supersonic flights accessible and affordable for business travelers, while also promoting sustainability in aviation. Overture features advanced aerodynamics and engines that support the use of next-generation sustainable alternative fuels, enhancing safety and efficiency. Boom Supersonic is committed to overcoming the challenges associated with supersonic flight, with the ultimate goal of establishing routine supersonic travel for passengers worldwide.

Alto Pharmacy

Series C in 2018
Alto is a full-service pharmacy powered by a team of experts dedicated to making your doctor's orders their own. From delivering prescriptions to coordinating with insurance, digging for discounts, and answering, Alto works behind-the-scenes to remove any obstacles standing in the way of your care. The company started in 2015 and is headquartered in San Francisco, California.

Finless Foods

Seed Round in 2018
Finless Foods Inc. is a biotechnology company based in Emeryville, California, focused on producing sustainable seafood alternatives through cellular agriculture technologies. Founded in 2017, the company specializes in growing marine-animal cells to create seafood products, including bluefin tuna. Finless Foods aims to provide a healthier and environmentally friendly alternative to traditionally caught and farmed seafood, offering consumers a cost-effective option that does not compromise on taste or dietary preferences. The company's mission is to develop and mass manufacture innovative marine animal food products that promote sustainability and accessibility in the seafood market.
Founded by mobile ad industry veterans, Downstream.ai is building the most scalable, self-serve mobile programmatic advertising solution for the world’s fastest growing businesses. Downstream’s proprietary software allows companies to control mobile RTB with powerful plug-and-play access to in-app and connected TV traffic on the largest mobile ad exchanges through a single dashboard with no coding required. Downstream leverages secure first and third party data to help marketers build scalable campaigns in minutes and at a fraction of the cost. Advertisers benefit from more transparent, granular control of their real time bidding, with a pricing model that scales better for both agencies and direct advertisers. Downstream is backed by London Venture Partners, Otter Consulting, Olive Tree Capital, Ride Ventures, The Gramercy Fund, Rising Tide Fund and a group of prominent industry angel investors. Downstream is headquartered in San Francisco with an office in New York City.

Kaleido BioSciences

Series B in 2017
Kaleido Biosciences is a clinical-stage healthcare company based in Lexington, Massachusetts, dedicated to developing microbiome metabolic therapies (MMTs) aimed at treating various diseases and improving human health. Founded in 2015, the company is advancing a diverse pipeline of MMT candidates targeting conditions such as urea cycle disorders, hepatic encephalopathy, multi-drug resistant infections, cardiometabolic and liver diseases, and immune oncology. Kaleido employs a unique, chemistry-driven approach to harness the microbiome's potential, focusing on modulating its metabolic output and profile by influencing the existing microbial functions. The company has established collaborations with notable institutions, including Gustave Roussy Cancer Center and Washington University School of Medicine, to further explore the applications of MMTs in immuno-oncology and other health conditions.

Indigo

Series C in 2016
Indigo Ag, Inc. operates an online platform that connects farmers with buyers and grain marketing advisors, facilitating the sale of grains. Founded in 2013 and headquartered in Boston, Massachusetts, the company aims to help farmers sustainably enhance their productivity and profitability through the use of beneficial plant microbes. By optimizing crop health and yield, Indigo's offerings enable farmers to implement regenerative agricultural practices while meeting specific buyer requirements for crop quality. The platform also supports growers with year-round partnerships and microbiome treatments tailored to improve farm management. Indigo operates in various locations worldwide, including Memphis, Research Triangle Park, Sydney, Buenos Aires, São Paulo, Basel, and Mumbai, reflecting its commitment to serving the agricultural community globally.

Koio

Seed Round in 2016
Koio Collective is a consumer goods company that offers calf-skin leathers and hand-finished footwear for gents and ladies. The company is driven by its mission is to to create their personal dream shoe, one that would accompany them on any quest and adapt to any situation. The company was founded in 2014 and headquartered in New York, United States.

Koio

Seed Round in 2016
Koio Collective is a consumer goods company that offers calf-skin leathers and hand-finished footwear for gents and ladies. The company is driven by its mission is to to create their personal dream shoe, one that would accompany them on any quest and adapt to any situation. The company was founded in 2014 and headquartered in New York, United States.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.